David Liu

Plus aucun poste en cours

Profil

David Y.
Liu was the founder of Trenovus, Inc. (founded in 2010) where he held the title of Chief Operating Officer from 2010 to 2012.
He previously worked at Scios, Inc. from 1992 to 2002 as Director-Inflammation Research and at FibroGen, Inc. from 2002 to 2010 as Vice President-Research.
Dr. Liu also worked at Harvard Medical School from 1976 to 1986 as Assistant Professor-Medicine Department.
He is currently the Chief Research & Development Strategy Officer at Protagonist Therapeutics, Inc. (since 2013).
Dr. Liu holds a doctorate degree from Michigan State University and an undergraduate degree from The University of Chicago.

Anciens postes connus de David Liu

Sociétés	Poste	Fin
PROTAGONIST THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	01/01/2023
Trenovus, Inc.	Fondateur	01/01/2012
FIBROGEN, INC.	Directeur Technique/Scientifique/R&D	01/01/2010
Scios, Inc.	Corporate Officer/Principal	01/01/2002
Harvard Medical School	Corporate Officer/Principal	01/01/1986

Formation de David Liu

Michigan State University	Doctorate Degree
The University of Chicago	Undergraduate Degree